Legionella Testing Market is projected to grow from USD 296 million in 2022 to USD 439 million by 2027, at a CAGR of 8.2% from 2022 to 2027, according to a new report by MarketsandMarkets. The increasing need for rapid diagnostics, increasing incidence of disease, growing advancements in bacterial testing, and water testing regulations.

Browse in-depth TOC on Legionella Testing Market

146 Tables

47 Figures

208 Pages

Download Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=173145333

List of Key Players:

The major players operating in this legionella testing market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), IDEXX Laboratories, Inc. (US), bioMrieux S.A. (France), Becton, Dickinson, and Company (US), Alere, Inc. (US), Eurofins Scientific (Luxembourg), Roche Diagnostics (Switzerland), Pall Corporation (Danaher) (US), Quidel Corporation (US), Eiken Chemical Co., Ltd. (Japan), Hologic, Inc. (US), QIAGEN (Germany), Takara Bio, Inc. (Japan), Environmental Safety Technologies, Inc. (US), Hydrosense (Scotland), Accepta Ltd. (UK), LuminUltra Technologies Ltd. (Canada), Pro-Lab Diagnostics, Inc. (Canada), BioAlert Solutions (Canada), Pacific Water Technology (Australia), Aquacert Ltd. (UK), DTK Water (UK), Sens Solutions (Spain), Genomadix, Inc. (US), and Phigenics, LLC (US).

Legionella Testing Market Dynamics

Drivers: Rapid increase of pneumonia and Legionella-related illnesses

According to the European Centre for Disease Prevention and Control (ECDC) (May 2022), Legionnaires' disease remains an uncommon and mainly sporadic respiratory infection with an overall notification rate of 1.9 cases per 100,000 population for the EU/EEA in 2020. France, Germany, Italy, and Spain accounted for 72% of all notified cases.

Opportunities: Legal requirements for water testing

The Environment Protection Agency (EPA) (October 2021) sets legal limits on over 90 contaminants in the US for drinking water. The legal limit for a contaminant reflects the level that protects human health and that water systems can achieve using the best available technology. EPA rules also set water-testing schedules and methods that water systems must follow.

Restraints: lack of reimbursement policies

The major factor restraining the growth of the market is inadequate reimbursements. According to MedPAC (Medicare Payment Advisory Commission), medical testing has seen a 40% decline in reimbursement over the last 40 years. This decline and additional budgetary concerns among healthcare systems will be a major obstacle to implementing novel diagnostic techniques in clinical laboratories.

Challenges: Difficulties in detection

The most common cause of Legionnaire's disease is Legionella pneumophilia serogroup 1, which can be quickly and easily identified via the urine antigen test. Legionnaire's disease can also go undetected once a patient is diagnosed with pneumonia. Best practises dictate that all hospital-acquired pneumonia patients be tested for Legionella in hopes of detecting and preventing a possible outbreak.

North America is the largest regional market for legionella testing market

The global market is segmented into five major regionsNorth America, Europe, the Asia Pacific, Latin America, and the Middle East Africa. In 2021, North America accounted for the largest share of the market. The North American market growth can be attributed to the growing incidence of legionella-related diseases and growing elderly population.

Recent Developments

• IDEXX Laboratories, Inc. (US) acquired Reference Laboratories (Finland) to expanded the companys international reference laboratory presence.
• LuminUltra Technologies Ltd. (Canada) launched launched GeneCount qPCR, a rapid onsite molecular testing solution.
• Eurofins Scientific (Luxembourg) acquired SunDream Group (Taiwan) to boost its environmental testing capabilities, as SunDream is the second-largest player in the environmental testing segment in Taiwan.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=173145333